BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33475071)

  • 21. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
    Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
    Long W; Liu S; Li XX; Shen X; Zeng J; Luo JS; Li KR; Wu AG; Yu L; Qin DL; Hu GQ; Yang J; Wu JM
    Pharmacol Res; 2021 Apr; 166():105491. PubMed ID: 33582247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
    Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
    Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA-1 is expressed in acute erythroblastic leukaemia.
    Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
    Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
    Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
    Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.
    Piqué-Borràs MR; Jevtic Z; Bagger FO; Seguin J; Sivalingam R; Bezerra MF; Louwagie A; Juge S; Nellas I; Ivanek R; Tzankov A; Moll UM; Cantillo O; Schulz-Heddergott R; Fagnan A; Mercher T; Schwaller J
    Blood; 2023 May; 141(18):2245-2260. PubMed ID: 36735909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
    Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
    Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
    Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C
    Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
    Karacay B; Chang LS
    Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
    Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
    Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine erythroleukemia cells contain two distinct GATA-binding proteins that have different patterns of expression during cellular differentiation.
    Aumont FL; Trudel P; Wall L
    Differentiation; 1993 Jan; 52(2):169-76. PubMed ID: 8472887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute erythroid leukemia: autopsy report of a rare disease.
    Ferreira CR; Lima FR; Goto EH; Kim EIM; Smeili LAA; de Campos FPF; Zerbini MCN
    Autops Case Rep; 2011; 1(4):11-20. PubMed ID: 31528548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of a new erythroblastic leukemia cell line, EEB: phosphatidylglucoside-mediated erythroid differentiation and apoptosis.
    Kawano-Yamamoto C; Muroi K; Nagatsuka Y; Higuchi M; Kikuchi S; Nagai T; Hakomori SI; Ozawa K
    Leuk Res; 2006 Jul; 30(7):829-39. PubMed ID: 16332389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Sportoletti P; Sorcini D; Guzman AG; Reyes JM; Stella A; Marra A; Sartori S; Brunetti L; Rossi R; Papa BD; Adamo FM; Pianigiani G; Betti C; Scialdone A; Guarente V; Spinozzi G; Tini V; Martelli MP; Goodell MA; Falini B
    Leukemia; 2021 Jul; 35(7):1949-1963. PubMed ID: 33159179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional activity of erythroid Kruppel-like factor (EKLF/KLF1) modulated by PIAS3 (protein inhibitor of activated STAT3).
    Siatecka M; Soni S; Planutis A; Bieker JJ
    J Biol Chem; 2015 Apr; 290(15):9929-40. PubMed ID: 25713074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
    Choe KS; Radparvar F; Matushansky I; Rekhtman N; Han X; Skoultchi AI
    Cancer Res; 2003 Oct; 63(19):6363-9. PubMed ID: 14559825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.
    Gentner E; Vegi NM; Mulaw MA; Mandal T; Bamezai S; Claus R; Tasdogan A; Quintanilla-Martinez L; Grunenberg A; Döhner K; Döhner H; Bullinger L; Haferlach T; Buske C; Rawat VP; Feuring-Buske M
    Oncotarget; 2016 Dec; 7(52):86889-86901. PubMed ID: 27888632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.